Importantly, it allows for preclinical testing of targeted therapies in BRAF GIST, offering new insights into treatment strategies.<h4>Significance</h4>This is the first fully penetrant mouse model of BRAF-driven GIST by inducing BRAFV600E in c-Kit+ ICC. Here, KIT is linked to intrahepatic cholangiocarcinoma.